Jason Taylor

And you find a lot of systems who have uncertain investments, not enough time to look at it, not enough people to go kind of investigate what I should be doing. And it's causing a little bit of paralysis, right? So that that's the health care provider side.

And you find a lot of systems who have uncertain investments, not enough time to look at it, not enough people to go kind of investigate what I should be doing. And it's causing a little bit of paralysis, right? So that that's the health care provider side.

What it's doing on the tech side is causing a ton of uncertainty for a lot of very innovative, very kind of mission driven or positive minded firms with these great innovations. And they're facing a market that's kind of taking a taking a pause, catching its breath, not really buying a lot very quickly. And it's going to cause a little bit of a bubble.

What it's doing on the tech side is causing a ton of uncertainty for a lot of very innovative, very kind of mission driven or positive minded firms with these great innovations. And they're facing a market that's kind of taking a taking a pause, catching its breath, not really buying a lot very quickly. And it's going to cause a little bit of a bubble.

There's a lot of companies with VC investment or outside investment that have expectations and milestones. And they're facing a pretty tough year as, you know, some of these firms have gone a little too fast. They've overinvested in tech for two years. Now they're sitting there with uncertainty in the market. They don't know what to do. So what we're tracking this year.

There's a lot of companies with VC investment or outside investment that have expectations and milestones. And they're facing a pretty tough year as, you know, some of these firms have gone a little too fast. They've overinvested in tech for two years. Now they're sitting there with uncertainty in the market. They don't know what to do. So what we're tracking this year.

What I'm spending a lot of time on is how are these innovative, smaller health tech firms going to navigate this uncertainty, especially when the health systems themselves may not be in a position to be much use or to be very advising in that context?

What I'm spending a lot of time on is how are these innovative, smaller health tech firms going to navigate this uncertainty, especially when the health systems themselves may not be in a position to be much use or to be very advising in that context?

Yeah. I think they are stuck to some extent and they're relying on each other, which is great. There's an awesome community in health care. They're also relying on third parties, including people like myself, to come in and help them try and navigate. But you said it right. There's actually a group, those 30 or 40 systems, they're in a position where they are overtly saying we want to fail fast.

Yeah. I think they are stuck to some extent and they're relying on each other, which is great. There's an awesome community in health care. They're also relying on third parties, including people like myself, to come in and help them try and navigate. But you said it right. There's actually a group, those 30 or 40 systems, they're in a position where they are overtly saying we want to fail fast.

The rest of them are in a position of saying we can't afford to fail at all. You know, if we have one project failure, it actually could turn into a full year, year and a half impact on their IT budget because that money is gone or slow or not able to deploy. The biggest problem that they have is actually spam. So if you look at, you know, I live in Los Angeles.

The rest of them are in a position of saying we can't afford to fail at all. You know, if we have one project failure, it actually could turn into a full year, year and a half impact on their IT budget because that money is gone or slow or not able to deploy. The biggest problem that they have is actually spam. So if you look at, you know, I live in Los Angeles.

One of my favorite close to my heart health systems is MLK Healthcare, which is in Watts, which is a little south of where I live. And they serve a primarily Hispanic community. They've got a lot of people on Medicaid or Medi-Cal as we call it out here. And it's an underserved community. They do fantastic work, but their IT staff is anemic compared with some of the larger systems.

One of my favorite close to my heart health systems is MLK Healthcare, which is in Watts, which is a little south of where I live. And they serve a primarily Hispanic community. They've got a lot of people on Medicaid or Medi-Cal as we call it out here. And it's an underserved community. They do fantastic work, but their IT staff is anemic compared with some of the larger systems.

And the breadth of understanding that it takes those leaders to be able to get their head around 100, 120 different topics that could come at them from a digital perspective or from a health tech perspective, it's just unfathomable. They can't go from one meeting to the next and be experts at everything. And so what ends up happening is a pure kind of Maslow version, right?

And the breadth of understanding that it takes those leaders to be able to get their head around 100, 120 different topics that could come at them from a digital perspective or from a health tech perspective, it's just unfathomable. They can't go from one meeting to the next and be experts at everything. And so what ends up happening is a pure kind of Maslow version, right?

They will focus on the things that must be focused on. They'll focus on resiliency. Business recovery, cyber, and then maybe they have time for one other thing. And in times like this, it's going to be something related to RevCycle where they can prove to the CFO that there's a material ROI coming out the back end.

They will focus on the things that must be focused on. They'll focus on resiliency. Business recovery, cyber, and then maybe they have time for one other thing. And in times like this, it's going to be something related to RevCycle where they can prove to the CFO that there's a material ROI coming out the back end.

They don't have the luxury of investing in some of the more softer return things like population health or patient access or patient experience type things. type of solutions. And so it almost creates a bigger divide, too, where you get these underserved communities, the systems serving them don't have the ability to invest.

They don't have the luxury of investing in some of the more softer return things like population health or patient access or patient experience type things. type of solutions. And so it almost creates a bigger divide, too, where you get these underserved communities, the systems serving them don't have the ability to invest.